TIROBIF 12.5 mg/50 ml Concentrate for Solution for IV Infusion

For the treatment of advanced thromboangiitis obliterans (Buerger disease) with critical limb ischemia when revascularization is not indicated; severe peripheral arterial occlusive disease, particularly in patients at risk of amputation for whom surgery or angioplasty is not possible; and severe, disabling Raynaud phenomenon that is unresponsive to other treatments.

Used for the prophylaxis of deep vein thrombosis, pulmonary embolism, and arterial thromboembolic events; the treatment of deep vein thrombosis, pulmonary embolism, unstable angina pectoris, acute myocardial infarction, and acute peripheral arterial occlusion; the prophylaxis of mural thrombosis following myocardial infarction; and during extracorporeal circulation and hemodialysis.

Used for iron deficiency anemia in patients with impaired gastrointestinal iron absorption, active gastrointestinal bleeding, or a history of total or subtotal gastrectomy; when oral iron therapy is not tolerated or is ineffective; when rapid iron supplementation is clinically required; and for iron deficiency in patients with chronic renal failure who are receiving erythropoietin therapy, whether or not they are dialysis-dependent.